Literature DB >> 19001348

Cytosolic prostaglandin E synthase: expression patterns in control and Alzheimer's disease brains.

Uzma A Chaudhry1, Sylvain Dore.   

Abstract

Anti-inflammatory drugs reduce the risk of Alzheimer's disease but fail to slow its progression. Studying the expression of prostaglandin E(2) synthases downstream of cyclooxygenase-2 is important. Here, the expression patterns of cytosolic prostaglandin E( 2) synthases, an immediate prostaglandin E(2) source was investigated. Sections taken from the middle frontal gyrus of brains of 10 patients with Alzheimer's and 5 age-matched controls were examined by immunostaining for the presence of the synthases. Immunofluorescence analysis of control brains showed that cytosolic prostaglandin E(2) synthases co-localize with microglia, neurons, and endothelium markers, but not with astrocytes or smooth muscle cells. Immunohistochemical staining for the synthases was positive in the pyramidal neurons of controls but barely detectable in the brain of Alzheimer's patients. These findings revealed that cytosolic prostaglandin E(2) synthases is found in microglia, neurons, and endothelium of control human middle frontal gyrus and that its levels decrease in pyramidal cells of Alzheimer's disease brains.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19001348      PMCID: PMC2859688          DOI: 10.1177/1533317508323655

Source DB:  PubMed          Journal:  Am J Alzheimers Dis Other Demen        ISSN: 1533-3175            Impact factor:   2.035


  22 in total

1.  Downregulation of neuronal cyclooxygenase-2 expression in end stage Alzheimer's disease.

Authors:  A V Yermakova; M K O'Banion
Journal:  Neurobiol Aging       Date:  2001 Nov-Dec       Impact factor: 4.673

2.  Age-dependent differences in glutamate-induced phosphorylation systems in rat hippocampal slices.

Authors:  F Angenstein; K Buchner; S Staak
Journal:  Hippocampus       Date:  1999       Impact factor: 3.899

3.  Casein kinase II preferentially phosphorylates human tau isoforms containing an amino-terminal insert. Identification of threonine 39 as the primary phosphate acceptor.

Authors:  J A Greenwood; C W Scott; R C Spreen; C B Caputo; G V Johnson
Journal:  J Biol Chem       Date:  1994-02-11       Impact factor: 5.157

4.  Knockout mice lacking cPGES/p23, a constitutively expressed PGE2 synthetic enzyme, are peri-natally lethal.

Authors:  Yoshihito Nakatani; Yutaka Hokonohara; Shigeru Kakuta; Katsuko Sudo; Yoichiro Iwakura; Ichiro Kudo
Journal:  Biochem Biophys Res Commun       Date:  2007-08-09       Impact factor: 3.575

Review 5.  Neuropathological stageing of Alzheimer-related changes.

Authors:  H Braak; E Braak
Journal:  Acta Neuropathol       Date:  1991       Impact factor: 17.088

6.  Casein kinase II alteration precedes tau accumulation in tangle formation.

Authors:  E Masliah; D S Iimoto; M Mallory; T Albright; L Hansen; T Saitoh
Journal:  Am J Pathol       Date:  1992-02       Impact factor: 4.307

7.  Elevated microsomal prostaglandin-E synthase-1 in Alzheimer's disease.

Authors:  Uzma A Chaudhry; Hean Zhuang; Barbara J Crain; Sylvain Doré
Journal:  Alzheimers Dement       Date:  2007-12-21       Impact factor: 21.566

8.  NMDA receptor mediates tau-induced neurotoxicity by calpain and ERK/MAPK activation.

Authors:  Giuseppina Amadoro; Maria Teresa Ciotti; Marco Costanzi; Vincenzo Cestari; Pietro Calissano; Nadia Canu
Journal:  Proc Natl Acad Sci U S A       Date:  2006-02-13       Impact factor: 11.205

9.  Regulation of cytosolic prostaglandin E synthase by phosphorylation.

Authors:  Tsuyoshi Kobayashi; Yoshihito Nakatani; Toshihiro Tanioka; Masafumi Tsujimoto; Shigeo Nakajo; Kazuyasu Nakaya; Makoto Murakami; Ichiro Kudo
Journal:  Biochem J       Date:  2004-07-01       Impact factor: 3.857

10.  Interleukin-1 mediates Alzheimer and Lewy body pathologies.

Authors:  W Sue T Griffin; Ling Liu; Yuekui Li; Robert E Mrak; Steven W Barger
Journal:  J Neuroinflammation       Date:  2006-03-16       Impact factor: 8.322

View more
  5 in total

1.  Microsomal prostaglandin E synthase-2: cellular distribution and expression in Alzheimer's disease.

Authors:  Uzma Chaudhry; Hean Zhuang; Sylvain Doré
Journal:  Exp Neurol       Date:  2009-08-05       Impact factor: 5.330

2.  Quantitative phosphoproteomics of Alzheimer's disease reveals cross-talk between kinases and small heat shock proteins.

Authors:  Eric B Dammer; Andrew K Lee; Duc M Duong; Marla Gearing; James J Lah; Allan I Levey; Nicholas T Seyfried
Journal:  Proteomics       Date:  2014-12-17       Impact factor: 3.984

Review 3.  Prostaglandin E2 synthases in neurologic homeostasis and disease.

Authors:  M Kerry O'Banion
Journal:  Prostaglandins Other Lipid Mediat       Date:  2009-04-22       Impact factor: 3.072

Review 4.  The Role of Eicosanoids in Alzheimer's Disease.

Authors:  Roger G Biringer
Journal:  Int J Environ Res Public Health       Date:  2019-07-18       Impact factor: 3.390

5.  Identification of a Pain-Specific Gene Expression Profile for Pediatric Recurrent Abdominal Pain.

Authors:  Adam B Willits; Victoria Grossi; Nicole C Glidden; Jeffrey S Hyams; Erin E Young
Journal:  Front Pain Res (Lausanne)       Date:  2021-11-05
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.